Pfizer Fellowship Grant Request for Proposals: 2026 Hemophilia Fellowship – United States
This Pfizer fellowship funds US academic institutions to train future leaders in hemophilia care through education, mentorship, and multidisciplinary, patient-centered approaches.
Funder: Pfizer Inc.
Due Dates: May 28, 2026 (original) | June 30, 2026 (extended)
Funding Amounts: Up to $100,000 for a one-year institution-based fellowship; funds cover fellow salary and benefits only.
Summary: Supports US academic institutions to advance equitable, patient-centered hemophilia care through education, mentorship, and multidisciplinary training.
Key Information: Applications submitted after June 30, 2026, 23:59 EST will not be reviewed.
Description
This competitive grant program aims to strengthen hemophilia care in the United States by supporting institution-based fellowships that emphasize equitable education, patient-centered shared decision making (SDM), and multidisciplinary team-based care. The program encourages institutions with established clinical training programs to address educational needs and barriers for People Living with Hemophilia (PLWH) in the context of a rapidly evolving treatment landscape. Structured education, SDM training, mentorship, and a practical capstone project are strongly encouraged. The selected institution should demonstrate a robust commitment to clinical practice, research, and education, with the goal of advancing knowledge and fostering the next generation of hemophilia care leaders.
